Seeing the Larger Picture on Patient Risk

There may be doubt around many aspects of healthcare at present, but one aspect that isn ’t in question is the transition to value-based care. It makes too much sense and fits with the goals of improving healthcare regardless of which side of the aisle you sit.In the future, life sciences organizations will take on more risk for certain patients, a trend that has many concerned as they quickly discover that they don ’t know what they don’t know about patients. This makes it difficult to make good decisions on the level of risk they are willing to accept.Consider an example of a patient prescribed a medication for diabetes. Under value-based care principles, the life sciences company will be asked to assume a level of financial risk related to the medication or device. Yet, it is difficult to accept risk without knowing more about that patient ’s overall condition. What if the patient has lower back pain and part of the success of treatment depends on regular exercise? The company may end up accepting more risk than it should. Even though factors may have been outside of its control, it may also gain an undeserved reputation for its pro ducts not working, hurting future sales.To avoid these types of situations – and ensure the best health outcomes for patients – it is important for life sciences organizations and health plans/payers to break down their usual siloes and start sharing their data for the common good.Connecting the dotsPayers are the connective tissue ...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news